Jason Butler
Stock Analyst at Citizens JMP
(4.79)
# 527
Out of 4,356 analysts
760
Total ratings
49.5%
Success rate
17.3%
Average return
Main Sectors:
Stocks Rated by Jason Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GHRS GH Research | Maintained: Buy | $42 → $39 | $23.99 | +62.57% | 24 | May 15, 2026 | |
| PGEN Precigen | Maintained: Buy | $9 → $11 | $4.34 | +153.46% | 49 | May 14, 2026 | |
| AVTX Avalo Therapeutics | Maintained: Buy | $62 → $55 | $15.95 | +244.83% | 3 | May 14, 2026 | |
| PRTA Prothena Corporation | Maintained: Buy | $19 → $20 | $10.18 | +96.46% | 27 | May 8, 2026 | |
| NERV Minerva Neurosciences | Initiated Coverage: Buy | $14 | $4.91 | +185.13% | 19 | Apr 15, 2026 | |
| NSRX Nasus Pharma | Maintained: Buy | $19 → $18 | $3.36 | +435.71% | 2 | Mar 26, 2026 | |
| ARGX argenx SE | Maintained: Buy | $699 → $944 | $835.99 | +12.92% | 42 | Feb 27, 2026 | |
| ACAD ACADIA Pharmaceuticals | Maintained: Buy | $38 → $35 | $21.66 | +61.59% | 48 | Feb 26, 2026 | |
| IRWD Ironwood Pharmaceuticals | Maintained: Buy | $8 → $10 | $3.57 | +180.11% | 19 | Feb 26, 2026 | |
| CYTK Cytokinetics | Maintained: Buy | $88 → $96 | $76.76 | +25.07% | 62 | Feb 25, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $114 → $131 | $132.63 | -1.23% | 13 | Dec 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.30 | - | 32 | Dec 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $19 | $5.24 | +262.60% | 1 | Nov 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $77 → $80 | $39.50 | +102.53% | 6 | Nov 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $91 → $92 | $66.54 | +38.26% | 48 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $9 → $12 | $4.02 | +198.51% | 53 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $3.13 | +27.80% | 49 | Sep 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $19 → $22 | $8.44 | +160.66% | 43 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $19 → $18 | $11.59 | +55.31% | 9 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $9.66 | n/a | 34 | May 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $42 → $38 | $17.62 | n/a | 29 | May 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $0.001 | n/a | 38 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0002 | n/a | 31 | Dec 27, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.229 | n/a | 13 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $1.15 | n/a | 8 | Jun 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $5.06 | n/a | 9 | Apr 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $0.0001 | n/a | 5 | Sep 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $2.73 | n/a | 5 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | €361.09 | $720.80 | n/a | 1 | Feb 1, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $58 → $70 | $89.78 | n/a | 3 | Jan 9, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $3.48 | n/a | 7 | Sep 5, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $4.65 | n/a | 3 | Mar 28, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $52 | $6.45 | n/a | 8 | Feb 14, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $23.44 | n/a | 4 | Nov 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $17 | $3.12 | n/a | 1 | Oct 18, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $340.86 | n/a | 1 | Jul 28, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $3.77 | n/a | 5 | May 10, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 → $2 | $33.33 | n/a | 2 | Aug 16, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | n/a | $9.31 | n/a | 1 | May 22, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $10.78 | n/a | 2 | May 6, 2013 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $2.85 | n/a | 1 | Mar 26, 2013 |
GH Research
May 15, 2026
Maintained: Buy
Price Target: $42 → $39
Current: $23.99
Upside: +62.57%
Precigen
May 14, 2026
Maintained: Buy
Price Target: $9 → $11
Current: $4.34
Upside: +153.46%
Avalo Therapeutics
May 14, 2026
Maintained: Buy
Price Target: $62 → $55
Current: $15.95
Upside: +244.83%
Prothena Corporation
May 8, 2026
Maintained: Buy
Price Target: $19 → $20
Current: $10.18
Upside: +96.46%
Minerva Neurosciences
Apr 15, 2026
Initiated Coverage: Buy
Price Target: $14
Current: $4.91
Upside: +185.13%
Nasus Pharma
Mar 26, 2026
Maintained: Buy
Price Target: $19 → $18
Current: $3.36
Upside: +435.71%
argenx SE
Feb 27, 2026
Maintained: Buy
Price Target: $699 → $944
Current: $835.99
Upside: +12.92%
ACADIA Pharmaceuticals
Feb 26, 2026
Maintained: Buy
Price Target: $38 → $35
Current: $21.66
Upside: +61.59%
Ironwood Pharmaceuticals
Feb 26, 2026
Maintained: Buy
Price Target: $8 → $10
Current: $3.57
Upside: +180.11%
Cytokinetics
Feb 25, 2026
Maintained: Buy
Price Target: $88 → $96
Current: $76.76
Upside: +25.07%
Dec 16, 2025
Maintained: Buy
Price Target: $114 → $131
Current: $132.63
Upside: -1.23%
Dec 11, 2025
Downgraded: Hold
Price Target: n/a
Current: $3.30
Upside: -
Nov 25, 2025
Initiated Coverage: Buy
Price Target: $19
Current: $5.24
Upside: +262.60%
Nov 7, 2025
Maintained: Buy
Price Target: $77 → $80
Current: $39.50
Upside: +102.53%
Nov 4, 2025
Maintained: Buy
Price Target: $91 → $92
Current: $66.54
Upside: +38.26%
Oct 9, 2025
Maintained: Buy
Price Target: $9 → $12
Current: $4.02
Upside: +198.51%
Sep 22, 2025
Reiterated: Buy
Price Target: $4
Current: $3.13
Upside: +27.80%
Sep 9, 2025
Reiterated: Buy
Price Target: $19 → $22
Current: $8.44
Upside: +160.66%
Aug 13, 2025
Maintained: Buy
Price Target: $19 → $18
Current: $11.59
Upside: +55.31%
May 12, 2025
Reiterated: Hold
Price Target: n/a
Current: $9.66
Upside: n/a
May 7, 2025
Maintained: Buy
Price Target: $42 → $38
Current: $17.62
Upside: n/a
Dec 27, 2024
Downgraded: Hold
Price Target: n/a
Current: $0.001
Upside: n/a
Dec 27, 2024
Rated: Hold
Price Target: n/a
Current: $0.0002
Upside: n/a
Nov 3, 2023
Rated: Hold
Price Target: n/a
Current: $0.229
Upside: n/a
Jun 9, 2023
Rated: Hold
Price Target: n/a
Current: $1.15
Upside: n/a
Apr 6, 2023
Rated: Hold
Price Target: n/a
Current: $5.06
Upside: n/a
Sep 3, 2021
Rated: Hold
Price Target: n/a
Current: $0.0001
Upside: n/a
Aug 16, 2021
Reiterated: Hold
Price Target: n/a
Current: $2.73
Upside: n/a
Feb 1, 2021
Maintained: Buy
Price Target: €361.09
Current: $720.80
Upside: n/a
Jan 9, 2020
Maintained: Buy
Price Target: $58 → $70
Current: $89.78
Upside: n/a
Sep 5, 2019
Downgraded: Hold
Price Target: n/a
Current: $3.48
Upside: n/a
Mar 28, 2019
Downgraded: Hold
Price Target: n/a
Current: $4.65
Upside: n/a
Feb 14, 2019
Reiterated: Buy
Price Target: $52
Current: $6.45
Upside: n/a
Nov 8, 2016
Reiterated: Buy
Price Target: n/a
Current: $23.44
Upside: n/a
Oct 18, 2016
Reiterated: Buy
Price Target: $17
Current: $3.12
Upside: n/a
Jul 28, 2016
Reiterated: Buy
Price Target: $61
Current: $340.86
Upside: n/a
May 10, 2016
Reiterated: Hold
Price Target: n/a
Current: $3.77
Upside: n/a
Aug 16, 2013
Reiterated: Buy
Price Target: $6 → $2
Current: $33.33
Upside: n/a
May 22, 2013
Initiated Coverage: Hold
Price Target: n/a
Current: $9.31
Upside: n/a
May 6, 2013
Downgraded: Hold
Price Target: n/a
Current: $10.78
Upside: n/a
Mar 26, 2013
Downgraded: Hold
Price Target: n/a
Current: $2.85
Upside: n/a